4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Qinghai Biotech Pharmaceutical Group Limited (0876) operates in the Medical Instruments & Supplies industry and is headquartered in Central, Hong Kong with about 1,340 employees. Its market capitalization is roughly HK$183 million. In the fiscal year ended 2025-12-31, 0876 reported HK$139M in revenue and (HK$47M) in net income.
Qinghai Biotech Pharmaceutical Group Limited, an investment holding company, engages in the health care and dental business in the People's Republic of China and internationally.
Interactive charts & full statements → Open the 0876 valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | HK$139M | HK$185M | HK$186M | HK$192M | — |
| Gross Profit | HK$51M | HK$82M | HK$81M | HK$83M | — |
| Operating Income (EBIT) | (HK$52M) | (HK$23M) | (HK$41M) | (HK$65M) | — |
| Net Income | (HK$47M) | (HK$46M) | HK$8M | (HK$123M) | — |
HKD; HK$M / HK$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | HK$472M | HK$518M | HK$605M | HK$768M | — |
| Total Liabilities | HK$73M | HK$91M | HK$113M | HK$297M | — |
HKD; HK$M / HK$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 0876 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms